Tubulin/microtubules as novel clozapine targets
Abstract Aim Clozapine is currently the only effective drug for treatment‐resistant schizophrenia; nonetheless, its pharmacological mechanism remains unclear, and its administration is limited because of severe adverse effects. By comparing the binding proteins of clozapine and its derivative olanza...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2022-03-01
|
| Серія: | Neuropsychopharmacology Reports |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/npr2.12221 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|